Survodutide
Dual GLP-1/glucagon receptor agonist studied in metabolic and energy regulation research.
Mix and match any items — discount applies automatically at checkout.
Reminder email when it's time to reorder. No card on file. Cancel anytime from your account — or email support@aresresearchlab.com.
Earn 64 loyalty points on this purchase · 100 pts = $5 off
Create a Research Account to unlock full batch data, COAs, and priority releases.
Intended strictly for research and laboratory use only. Not for human consumption.
About Survodutide
Third-party purity testing available upon request.
Research Classification
Storage Information
Survodutide Purity & COA Verification
Read the Survodutide research
Research guide on Survodutide (BI 456906): dual GLP-1 / glucagon receptor agonism, MASLD and metabolic literature, and the documented side-effect profile.
Read article →Published benefits, side effects, and semaglutide/Retatrutide comparisons for tirzepatide — the GLP-1/GIP dual agonist that established GIP-receptor co-agonism as a productive metabolic axis.
Read article →Published benefits, side effects, and tirzepatide/semaglutide comparisons for Retatrutide — the investigational GLP-1/GIP/glucagon triple agonist with the largest body-weight reductions reported for any non-surgical incretin pharmacotherapy.
Read article →Reference dose tiers, titration ladder, reconstitution math, and weekly-injection scheduling from the published survodutide (GLP-1/glucagon dual agonist) research record.
Read article →Frequently bought together
Curated complements for this compound — researchers most often pair it with these.
Research Use Disclaimer
Researcher Reviews
Sign in with the account that placed your order to leave a verified review.
Ask the Lab
No public questions yet — be the first to ask.
Independent Certificate of Analysis
Independently tested by In-House Verification. Verified and batch-tracked by Ares Research. Additional reports available upon request.
No fillers. No shortcuts. Only verified compounds.
